GeniqueScreen®
GeniqueScreen® covers carrier status for inherited conditions and hereditary cancer risk, giving families clarity before they plan ahead.
What it covers
Carrier screening for inherited genetic conditions and hereditary cancer risk assessment.
What you get
Family-planning insights and, where relevant, a proactive understanding of inherited genetic conditions and hereditary cancer risk.
Who it's for
Couples planning a family and anyone wanting to understand inherited risk.
From sample to report
Analysed using GSA, WES or WGS in an accredited lab, with reports reviewed and explained by a certified genetic counsellor before release.
What the carrier panel tests
Carrier screening is a fixed-content test rather than a search. The panel is defined in advance, so the report tells you which of those conditions you carry and, just as usefully, which you do not.
- Panel content: 12,125 variants annotated Pathogenic or Likely Pathogenic, drawn from 1,465 genes.
- Method: genotyping on a custom Illumina Infinium microarray, with a detection rate above 99% for the variants on the panel.
- Confirmation: any variant reported is recommended for Sanger sequencing before it is acted on, to rule out a false positive.
- Limits: the panel covers the variants it lists and no others, so a clear result narrows inherited risk rather than removing it.
What the hereditary cancer panel tests
The cancer panel is the second half of GeniqueScreen® and is built the same way: a defined variant set, reported against a fixed list of conditions.
- Panel content: variants annotated Pathogenic or Likely Pathogenic across 97 genes associated with 46 diseases.
- Categories covered: breast and ovarian, colon, lung, prostate, pancreas, kidney, renal, thyroid, oesophagus, eye and skin cancers, alongside a group of cancer-related syndromes.
- Method: an array-based test covering a fixed set of variants, so a clear result speaks to the panel rather than to every possible cause.
- When it is not the right test: where there is a strong family history, or a sign of disease already present, the report directs the reader to further diagnostic testing rather than letting a clear screen stand as reassurance.
What a couple gets back
The carrier report is built around a reproductive decision, so it reads as a pair rather than as one individual.
- Both partners in one report: results sit side by side, with the partner column marked untested until the second sample is run.
- Reproductive risk as a figure: each positive finding carries the chance of an affected child, modelled on a pairing with an untested partner of the same ethnic group.
- The condition explained: inheritance pattern, the variant in standard HGVS notation, and a plain-language description of what the condition is and how it presents.
- Annexures: the full list of genes, variants and conditions tested is printed with every report, so the negative half of the result is auditable too.
- Counsellor review: every report is reviewed by a certified genetic counsellor before release, and onward carrier testing of a partner or of blood relatives is raised where a finding warrants it.
Available through clinics, laboratories and partners, not sold direct to the public
Interested in GeniqueScreen®?
Talk to our team about how it fits your needs.